Virbac SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0000031577
EUR
339.00
-1.5 (-0.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Virbac SA
EUROAPI SA
Valneva SE
Transgene SA
Inventiva SA
Acticor Biotech SAS
Pharnext SA
Aelis Farma SA
Afyren SAS
Valbiotis SA
genOway SA
Why is Virbac SA ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 24.65
2
Healthy long term growth as Operating profit has grown by an annual rate 10.75%
3
Flat results in Dec 24
  • CASH AND EQV(HY) Lowest at EUR 149.63 MM
4
With ROE of 12.82%, it has a Fair valuation with a 2.51 Price to Book Value
  • Over the past year, while the stock has generated a return of 4.79%, its profits have fallen by -2.4%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Virbac SA should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.50%
EBIT Growth (5y)
10.75%
EBIT to Interest (avg)
24.65
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
0.13
Sales to Capital Employed (avg)
1.20
Tax Ratio
26.05%
Dividend Payout Ratio
8.36%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
22.13%
ROE (avg)
16.62%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.51
EV to EBIT
14.32
EV to EBITDA
10.92
EV to Capital Employed
2.30
EV to Sales
1.98
PEG Ratio
NA
Dividend Yield
0.46%
ROCE (Latest)
16.02%
ROE (Latest)
12.82%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Virbac SA
Operating Cash Flow
Highest at EUR 318.92 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (EUR MM)

Dividend per share
Highest at EUR 5.49
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (EUR)

Depreciation
Highest at EUR 31.27 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (EUR MM)

Depreciation
At EUR 31.27 MM has Grown at 20.39%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (EUR MM)

Here's what is not working for Virbac SA
Cash and Eqv
Lowest at EUR 149.63 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents